International Biotechnology (LON:IBT – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 817.65 and traded as high as GBX 940. International Biotechnology shares last traded at GBX 918, with a volume of 83,252 shares changing hands.
International Biotechnology Price Performance
The firm has a market capitalization of £292.87 million, a PE ratio of -279.03 and a beta of 0.21. The firm has a 50-day simple moving average of GBX 961.23 and a 200-day simple moving average of GBX 817.65.
International Biotechnology (LON:IBT – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported GBX (11.42) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a return on equity of 13.67%. Equities analysts expect that International Biotechnology will post 0.9435943 earnings per share for the current year.
About International Biotechnology
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
See Also
- Five stocks we like better than International Biotechnology
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
